Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $770 is 48.98% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 770.26||$ 796.64|
|Low:||$ 755.69||$ 516.85|
ETFs with ATRI as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|2.55%||First Trust Small Cap US Equity Select ETF (RNSC)||-2.30 (-10.07%)|
|2.35%||Invesco DWA NASDAQ Momentum ETF (DWAQ)||-15.37 (-13.54%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
Atrion Corporation and its subsidiaries ("we," "our," "us," "Atrion," or the "Company") develop and manufacture products, primarily for medical applications. Our medical products are used in a number of fields including fluid delivery, cardiovascular and ophthalmology applications. Our fluid delivery products accounted for 44 percent of net revenues for 2017 and 42 percent of net revenues for both 2016 and 2015. We have developed a wide variety of proprietary valves designed to precisely fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields such as anesthesia and oncology. We make products that deliver fluids, as well as promote infection control in hospital and home healthcare environments. Our cardiovascular products accounted for 33 percent of net revenues for both 2017 and 2016 and 32 percent of net revenues for 2015. ... More ...
Nasdaq Official Price
Jan. 22, 2019
Jan. 22, 2019